JP2005518344A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005518344A5 JP2005518344A5 JP2003536383A JP2003536383A JP2005518344A5 JP 2005518344 A5 JP2005518344 A5 JP 2005518344A5 JP 2003536383 A JP2003536383 A JP 2003536383A JP 2003536383 A JP2003536383 A JP 2003536383A JP 2005518344 A5 JP2005518344 A5 JP 2005518344A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- binding protein
- polypeptide
- residues
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32883501P | 2001-10-15 | 2001-10-15 | |
| US34188101P | 2001-12-21 | 2001-12-21 | |
| PCT/US2002/032717 WO2003033653A2 (en) | 2001-10-15 | 2002-10-15 | Affinity enhancement agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005518344A JP2005518344A (ja) | 2005-06-23 |
| JP2005518344A5 true JP2005518344A5 (OSRAM) | 2006-01-05 |
| JP4443923B2 JP4443923B2 (ja) | 2010-03-31 |
Family
ID=26986533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003536383A Expired - Fee Related JP4443923B2 (ja) | 2001-10-15 | 2002-10-15 | 親和性向上剤 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20030113333A1 (OSRAM) |
| EP (1) | EP1444267B1 (OSRAM) |
| JP (1) | JP4443923B2 (OSRAM) |
| KR (1) | KR101027889B1 (OSRAM) |
| CN (1) | CN1604910A (OSRAM) |
| AU (1) | AU2002335808B2 (OSRAM) |
| BR (1) | BR0213284A (OSRAM) |
| CA (1) | CA2463616C (OSRAM) |
| IL (1) | IL161417A0 (OSRAM) |
| MX (1) | MXPA04003533A (OSRAM) |
| PL (1) | PL374426A1 (OSRAM) |
| RU (1) | RU2004114878A (OSRAM) |
| WO (1) | WO2003033653A2 (OSRAM) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6962702B2 (en) * | 1998-06-22 | 2005-11-08 | Immunomedics Inc. | Production and use of novel peptide-based agents for use with bi-specific antibodies |
| US6346454B1 (en) * | 1999-01-12 | 2002-02-12 | Agere Systems Guardian Corp. | Method of making dual damascene interconnect structure and metal electrode capacitor |
| AU2003209446B2 (en) * | 2002-03-01 | 2008-09-25 | Immunomedics, Inc. | Bispecific antibody point mutations for enhancing rate of clearance |
| US20050003403A1 (en) * | 2003-04-22 | 2005-01-06 | Rossi Edmund A. | Polyvalent protein complex |
| EP1638510B1 (en) * | 2003-07-01 | 2015-09-02 | Immunomedics, Inc. | Multivalent carriers of bi-specific antibodies |
| EP3332808B1 (en) | 2005-03-03 | 2020-09-09 | Immunomedics Inc. | Humanized l243 antibodies |
| CA2721980C (en) | 2008-04-21 | 2017-01-03 | The Regents Of The University Of California | Selective high-affinity poly dentate ligands and methods of making such |
| US9050375B2 (en) * | 2009-07-06 | 2015-06-09 | Hoffmann-La Roche, Inc. | Bi-specific digoxigenin binding antibodies |
| US9264453B2 (en) | 2013-11-08 | 2016-02-16 | At&T Mobility Ii Llc | Front end processor for short message service centers |
| AU2024233139A1 (en) * | 2023-03-03 | 2025-08-28 | Oncoone Research & Development Gmbh | Improved bispecific anti-tumor antigen/anti-hsg antibodies for pre-targeting of hyperproliferative disorders |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5618920A (en) * | 1985-11-01 | 1997-04-08 | Xoma Corporation | Modular assembly of antibody genes, antibodies prepared thereby and use |
| US4946778A (en) * | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| FR2604092B1 (fr) * | 1986-09-19 | 1990-04-13 | Immunotech Sa | Immunoreactifs destines a cibler les cellules animales pour leur visualisation ou leur destruction in vivo |
| US5258498A (en) * | 1987-05-21 | 1993-11-02 | Creative Biomolecules, Inc. | Polypeptide linkers for production of biosynthetic proteins |
| US5132405A (en) * | 1987-05-21 | 1992-07-21 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| GB8928874D0 (en) * | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
| US6027725A (en) * | 1991-11-25 | 2000-02-22 | Enzon, Inc. | Multivalent antigen-binding proteins |
| US6096289A (en) * | 1992-05-06 | 2000-08-01 | Immunomedics, Inc. | Intraoperative, intravascular, and endoscopic tumor and lesion detection, biopsy and therapy |
| EP0672068A4 (en) * | 1992-09-25 | 1997-02-26 | Commw Scient Ind Res Org | TARGET MOLECULES BINDING POLYPEPTIDES. |
| DK0672142T3 (da) * | 1992-12-04 | 2001-06-18 | Medical Res Council | Multivalente og multispecifikke bindingsproteiner samt fremstilling og anvendelse af disse |
| US5874540A (en) * | 1994-10-05 | 1999-02-23 | Immunomedics, Inc. | CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies |
| US5989830A (en) * | 1995-10-16 | 1999-11-23 | Unilever Patent Holdings Bv | Bifunctional or bivalent antibody fragment analogue |
| DE69729283T2 (de) * | 1996-03-20 | 2005-05-25 | Immunomedics, Inc. | GLYKOSYLIERTE IgG ANTIKÖRPER |
| DE69730209T2 (de) * | 1996-04-04 | 2005-04-14 | Unilever N.V. | Multivalentes und multispezifisches Antigenbindungsprotein |
| US6962702B2 (en) * | 1998-06-22 | 2005-11-08 | Immunomedics Inc. | Production and use of novel peptide-based agents for use with bi-specific antibodies |
| WO1999066951A2 (en) * | 1998-06-22 | 1999-12-29 | Immunomedics, Inc. | Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| IL162732A0 (en) * | 2001-12-26 | 2005-11-20 | Immunomedics Inc | Methods of generating multispecific, multivalent agents from hv and vl domains |
-
2002
- 2002-10-15 JP JP2003536383A patent/JP4443923B2/ja not_active Expired - Fee Related
- 2002-10-15 KR KR1020047005675A patent/KR101027889B1/ko not_active Expired - Fee Related
- 2002-10-15 BR BRPI0213284-2A patent/BR0213284A/pt not_active IP Right Cessation
- 2002-10-15 CA CA2463616A patent/CA2463616C/en not_active Expired - Fee Related
- 2002-10-15 AU AU2002335808A patent/AU2002335808B2/en not_active Ceased
- 2002-10-15 WO PCT/US2002/032717 patent/WO2003033653A2/en not_active Ceased
- 2002-10-15 MX MXPA04003533A patent/MXPA04003533A/es not_active Application Discontinuation
- 2002-10-15 RU RU2004114878/13A patent/RU2004114878A/ru not_active Application Discontinuation
- 2002-10-15 CN CNA028250710A patent/CN1604910A/zh active Pending
- 2002-10-15 IL IL16141702A patent/IL161417A0/xx unknown
- 2002-10-15 PL PL02374426A patent/PL374426A1/xx unknown
- 2002-10-15 US US10/270,071 patent/US20030113333A1/en not_active Abandoned
- 2002-10-15 EP EP02770573.0A patent/EP1444267B1/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7258006B2 (ja) | Ｉｌ－１７ａ結合タンパク質 | |
| JP2021502810A5 (OSRAM) | ||
| RU2004122702A (ru) | Способы получения полиспецифичных, поливалентных средств из vh и vl доменов | |
| CN110835371A (zh) | 抗ccr8单克隆抗体及其应用 | |
| JP2005514030A5 (OSRAM) | ||
| CN115947846A (zh) | 一种抗pd-l1纳米抗体及其衍生物和用途 | |
| JP2020508691A5 (OSRAM) | ||
| JPH08510376A (ja) | 新規な抗−ガン胎児性抗原キメラ抗体一族 | |
| JP2009521909A5 (OSRAM) | ||
| CN101903402A (zh) | 抗tl1a的人源化抗体 | |
| JP2010511388A5 (OSRAM) | ||
| JP2008515446A5 (OSRAM) | ||
| WO2013174264A1 (zh) | 抗BLyS抗体 | |
| JP2008535475A5 (OSRAM) | ||
| CA2598510A1 (en) | Q3 sparc deletion mutant and uses thereof | |
| JP2005518344A5 (OSRAM) | ||
| CN117062838A (zh) | 一种靶向bcma的纳米抗体及其应用 | |
| JP2008521426A5 (OSRAM) | ||
| JP2010514413A5 (OSRAM) | ||
| WO2021082573A1 (zh) | 抗il-4r单域抗体及其应用 | |
| CA2463616A1 (en) | Affinity enhancement agents | |
| CN116284405B (zh) | 靶向cd150蛋白的纳米抗体及其应用 | |
| JP7590785B2 (ja) | ヒト化抗ＩＬ－４Ｒα単一ドメイン抗体及びその使用 | |
| WO2020119707A1 (zh) | 抗il-17a抗体及其应用 | |
| CN117860786B (zh) | 基因修饰间充质干细胞在多种疾病中的制药用途和诊断用途 |